Browsing Tag
United States
338 posts
Oklo becomes the hottest nuclear stock of 2025—should you buy, hold, or wait?
Discover how Oklo Inc (NASDAQ: OKLO) rocketed past expectations despite losses—what’s fueling the nuclear stock surge and whether investors should lean in now.
Will America’s new H-1B visa fee crush Indian IT’s global delivery model?
Find out how the new $100,000 H-1B visa fee could shake up Indian IT operations, disrupt projects, and reshape global talent flows.
Will Trump’s $100,000 H-1B visa fee end America’s reliance on foreign tech talent?
Trump’s new $100,000 H-1B visa fee could reshape U.S. immigration and global tech hiring. Explore its impact on Indian talent, employers, and innovation.
Tutors International joins forces with My Homeschool Expert to simplify elite homeschooling for UHNW families in the US
Discover how Tutors International and My Homeschool Expert are transforming UHNW homeschooling with bespoke tutors and 50-state legal compliance.
Nucor (NYSE: NUE) shares tumble after Q3 forecast disappoints the market
Nucor (NYSE: NUE) shares dropped after Q3 2025 guidance missed expectations. Explore why margins are under pressure and what it means for investors.
Why GSK is investing $30bn in the U.S. now—and what it means for global pharma manufacturing
GSK to invest $30B in U.S. R&D and manufacturing amid trade policy shifts—find out how this shapes global pharma supply chains and investor sentiment.
Novo Nordisk eyes FDA approval for high-dose 7.2mg Wegovy after STEP UP trial shows 21% weight loss
Novo Nordisk seeks U.S. approval for 7.2mg Wegovy after 21% average weight loss in trials. Can it outpace Eli Lilly’s Zepbound in the obesity drug race?
Amazon sets ‘Prime Big Deal Days’ for October 7–8 to jump-start 2025 holiday shopping
Amazon confirms Prime Big Deal Days for Oct 7–8, with AI shopping tools, early deals, and stock momentum shaping this year’s holiday retail rush.
NanoVibronix (NASDAQ: NAOV) registers 1.35m shares for resale after reverse split, fueling volatility talk
NanoVibronix registers 1.35M shares for resale as holders seek liquidity. Will the post-split overhang pressure NAOV or offer trading opportunity?
Ferguson Enterprises (NYSE: FERG) Q4 earnings beat: $3.48 EPS, $8.5bn revenue—what’s behind the surprise?
Ferguson Enterprises (NYSE: FERG) posts $3.48 EPS and $8.5B revenue beat—find out how non-residential demand and margin control lifted results.